Everything you care about in one place
Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feederema.europa.eu
What's new
Get the latest updates from What's new directly as they happen.
Follow now 449 followers
Latest posts
Last updated about 20 hours ago
Human medicines European public assessment report (EPAR): Zumrad, sasanlimab, Status: Application withdrawn
about 21 hours ago
Human medicines European public assessment report (EPAR): Zumrad, sasanlimab, Status: Application withdrawn
Agenda of the CHMP meeting 14-17 September 2026
about 21 hours ago
Agenda of the CHMP meeting 14-17 September 2026
Human medicines European public assessment report (EPAR): Zonisamide Viatris (previously Zonisamide Mylan), zonisamide, Date of authorisation: 31/03/2016, Revision: 14, Status: Authorised
about 21 hours ago
Human medicines European public assessment report (EPAR): Zonisamide Viatris (previously Zonisamide Mylan)...
Human medicines European public assessment report (EPAR): Abrysvo, respiratory syncytial virus vaccine (bivalent, recombinant), Date of authorisation: 23/08/2023, Revision: 17, Status: Authorised
about 21 hours ago
Human medicines European public assessment report (EPAR): Abrysvo, respiratory syncytial virus vaccine...
Human medicines European public assessment report (EPAR): Idefirix, imlifidase, Date of authorisation: 25/08/2020, Revision: 10, Status: Authorised
about 21 hours ago
Human medicines European public assessment report (EPAR): Idefirix, imlifidase, Date of authorisation...
Human medicines European public assessment report (EPAR): Zynlonta, loncastuximab tesirine, Date of authorisation: 20/12/2022, Revision: 8, Status: Authorised
about 21 hours ago
Human medicines European public assessment report (EPAR): Zynlonta, loncastuximab tesirine, Date of...
Human medicines European public assessment report (EPAR): Fasenra, benralizumab, Date of authorisation: 08/01/2018, Revision: 17, Status: Authorised
about 21 hours ago
Human medicines European public assessment report (EPAR): Fasenra, benralizumab, Date of authorisation...
Human medicines European public assessment report (EPAR): Qdenga, dengue tetravalent vaccine (live, attenuated), Date of authorisation: 05/12/2022, Revision: 9, Status: Authorised
11 days ago
Human medicines European public assessment report (EPAR): Qdenga, dengue tetravalent vaccine (live...
Opinion on medicine for use outside EU: Dengue Tetravalent Vaccine (Live, Attenuated) Takeda, Dengue virus, serotype 2, expressing Dengue virus, serotype 1, surface proteins, live, attenuated,Dengue virus, serotype 2, expressing Dengue virus, serotype 3,
11 days ago
Opinion on medicine for use outside EU: Dengue Tetravalent Vaccine (Live, Attenuated)...